<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55447">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02052232</url>
  </required_header>
  <id_info>
    <org_study_id>BL19</org_study_id>
    <nct_id>NCT02052232</nct_id>
  </id_info>
  <brief_title>Study of Protein Metabolism in Healthy Older Subjects</brief_title>
  <official_title>Study of Acute Muscle Protein Metabolism in Healthy Older Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <authority>United Kingdom: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blinded, crossover study to evaluate muscle protein metabolism
      during fasting and feeding in healthy older subjects.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Protein Metabolism</measure>
    <time_frame>Change from - 1 to + 5 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Study Visit 1 and Study Visit 2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Macrovascular Blood Flow</measure>
    <time_frame>Change from -1 to +5 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Study Visit 1 and Study Visit 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic Markers</measure>
    <time_frame>Change from -1 to +5 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Study Visit 1 and Study Visit 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microvascular Blood Flow</measure>
    <time_frame>Change from -1 to +5 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Study Visit 1 and Study Visit 2</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control protein powder sachet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental protein powder sachet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental protein powder sachet</intervention_name>
    <description>mixed with 8 oz. water</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control protein powder sachet</intervention_name>
    <description>mixed with 8 oz. water</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 60 and ≤ 75 years

          -  Body Mass Index (BMI) &gt; 23.0 to &lt; 30.0

          -  Ability (with or without the aid of an assistive device) to climb a flight of 10
             stairs or walk an equivalent of 1 city block without assistance

          -  Currently not participating in a formal exercise or training program and agrees to
             refrain from intense physical activity from screening through the completion of the
             study.

        Exclusion Criteria:

          -  Diagnosis of diabetes

          -  Active pursuit of weight loss

          -  Poorly controlled hypertension or hypotension

          -  Untreated hypothyroidism or hyperthyroidism

          -  Anemia or abnormally functioning kidneys or liver

          -  A significant cardiovascular event within ≤ 6 months; or stated history of congestive
             heart failure; or evidence of clinically active cardiovascular disease assessed
             during the screening EKG

          -  Peripheral arterial disease or other diseases that preclude proper limb blood flow

          -  Chronic, contagious, infectious disease

          -  Current infection or corticosteroid treatment within the last 3 months

          -  Clotting or bleeding disorders, stated history of Deep Vein Thrombosis (DVT) and/or a
             known hypercoagulable condition

          -  In condition deemed unsuitable for study based upon study physician assessment

          -  Surgery requiring &gt;2 days of hospitalization in the last 3 weeks and/or planned
             elective surgery requiring &gt;2 days of hospitalization during the course of the study

          -  Current active malignant disease or was treated within the last 6 months for cancer

          -  An amputee

          -  Obstruction of the gastrointestinal tract, inflammatory bowel disease, short bowel
             syndrome or other forms of gastrointestinal disease

          -  Diagnosed with, or has a history of severe dementia or delirium, eating disorder,
             history of significant neurological or psychiatric disorder, alcoholism, substance
             abuse

          -  Cannot refrain from taking

               -  High doses of fish oil, or omega-3 supplements, or high doses of vitamin D

               -  Medications/dietary supplements/herbals or substances that are considered
                  anabolic, or reduce weight

               -  Any pulmonary anti-inflammatory medication or bronchodilators on the day of and
                  48 hours prior to study visits 1 and 2

               -  NSAIDS or acetaminophen on the day of and 48 hours prior to study visits 1 and 2

          -  Chronic use of nicotine

          -  Allergic or intolerant to any ingredient found in the study products
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Tian, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen S DeLuca, MS, RD, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bobbie Swearengin, RN</last_name>
    <phone>614-624-7182</phone>
    <email>bobbie.swearengin@abbott.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Nottingham</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3DT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Philip J Atherton, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>December 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
